Kalaris Therapeutics, Inc. (KLRS)

Kalaris Therapeutics Statistics

Total Valuation

KLRS has a market cap or net worth of $111.05 million. The enterprise value is $6.18 million.

Market Cap	111.05M
Enterprise Value	6.18M

Important Dates

The last earnings date was Tuesday, May 12, 2026, before market open.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

KLRS has 22.99 million shares outstanding. The number of shares has increased by 176.07% in one year.

Current Share Class	22.99M
Shares Outstanding	22.99M
Shares Change (YoY)	+176.07%
Shares Change (QoQ)	+21.95%
Owned by Insiders (%)	6.23%
Owned by Institutions (%)	18.55%
Float	6.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.67
P/TBV Ratio	1.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.19

Current Ratio	12.19
Quick Ratio	12.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-29.24

Financial Efficiency

Return on equity (ROE) is -66.60% and return on invested capital (ROIC) is -44.96%.

Return on Equity (ROE)	-66.60%
Return on Assets (ROA)	-27.97%
Return on Invested Capital (ROIC)	-44.96%
Return on Capital Employed (ROCE)	-46.82%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$2.20M
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +48.62% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+48.62%
50-Day Moving Average	6.10
200-Day Moving Average	6.49
Relative Strength Index (RSI)	37.05
Average Volume (20 Days)	91,797

Short Selling Information

The latest short interest is 805,754, so 3.50% of the outstanding shares have been sold short.

Short Interest	805,754
Short Previous Month	842,687
Short % of Shares Out	3.50%
Short % of Float	12.65%
Short Ratio (days to cover)	9.20

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-47.63M
Pretax Income	-44.10M
Net Income	-44.10M
EBITDA	n/a
EBIT	-47.63M
Earnings Per Share (EPS)	-$2.19

Balance Sheet

The company has $97.22 million in cash and n/a in debt, with a net cash position of $104.87 million or $4.56 per share.

Cash & Cash Equivalents	97.22M
Total Debt	n/a
Net Cash	104.87M
Net Cash Per Share	$4.56
Equity (Book Value)	68.56M
Book Value Per Share	2.89
Working Capital	90.39M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KLRS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-176.07%
Shareholder Yield	-176.07%
Earnings Yield	-39.71%
FCF Yield	n/a

Analyst Forecast

The average price target for KLRS is $18.75, which is 288.20% higher than the current price. The consensus rating is "Buy".

Price Target	$18.75
Price Target Difference	288.20%
Analyst Consensus	Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a